The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Congenital generalized lipodystrophy (CGL) and pulmonary arterial hypertension (PAH) have recently been associated with mutations in the caveolin‐1 (
CAV1
) gene, which encodes the primary structural protein of caveolae. However, little is currently known about how these
CAV1
mutations impact caveolae formation or contribute to the development of disease. Here, we identify a heterozygous F160X
CAV1
...
How the plasma membrane is bent to accommodate clathrin‐independent endocytosis remains uncertain. Recent studies suggest Shiga and cholera toxin induce membrane curvature required for their uptake into clathrin‐independent carriers by binding and cross‐linking multiple copies of their glycosphingolipid receptors on the plasma membrane. But it remains unclear if toxin‐induced sphingolipid crosslinking...
Caveolin‐1 (Cav1) is the primary scaffolding protein of caveolae, flask‐shaped invaginations of the plasma membrane thought to function in endocytosis, mechanotransduction, signaling and lipid homeostasis. A significant amount of our current knowledge about caveolins and caveolae is derived from studies of transiently overexpressed, C‐terminally tagged caveolin proteins. However, how different tags...
Mutations and alterations in caveolin‐1 expression levels have been linked to a number of human diseases. How misregulation of caveolin‐1 contributes to disease is not fully understood, but has been proposed to involve the intracellular accumulation of mutant forms of the protein. To better understand the molecular basis for trafficking defects that trap caveolin‐1 intracellularly, we compared the properties of a GFP‐tagged version of caveolin‐1 P132L, a mutant form of caveolin‐1 previously linked to breast cancer, with wild‐type caveolin‐1. Unexpectedly, wild‐type caveolin‐1‐GFP also accumulated intracellularly, leading us to examine the mechanisms underlying the abnormal localization of the wild type and mutant protein in more detail. We show that both the nature of the tag and cellular context impact the subcellular distribution of caveolin‐1, demonstrate that even the wild‐type form of caveolin‐1 can function as a dominant negative under some conditions, and identify specific conformation changes associated with incorrectly targeted forms of the protein. In addition, we find intracellular caveolin‐1 is phosphorylated on Tyr14, but phosphorylation is not required for mistrafficking of the protein. These findings identify novel properties of mistargeted forms of caveolin‐1 and raise the possibility that common trafficking defects underlie diseases associated with overexpression and mutations in caveolin‐1.
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.